USPTO serial 99199401
HEALTHBANK
Reviewed by CopyMark Law Group
Status 688Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- SOUDERS, MICHAEL J
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with HEALTHBANK?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $648*
Plus Government fees of $300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Bethesda, MD, US
Bethesda, MD, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael A. Geller
Michael A. Geller DLA Piper LLP (US)P.O. Box 64807Chicago, IL 60664-0807United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Immune cells, namely, cells for scientific, laboratory or medical research; tissue cells, namely, cells for scientific, laboratory or medical research; biological tissues, namely, stem cells, progenitor cells, immune cells, tumor cells, blood-derived cells, stromal cells, connective tissue, support tissue, organ tissue, adipose and soft tissue, vascular tissue, skin and surface tissues, mucosal tissue, neural tissue, decellularized tissue, demineralized tissue, umbilical cords, placentas, bone marrow and tumor tissue for scientific, laboratory and medical research use; derivatives of immune cells, tissue cells, and biological tissues, namely, proteins, peptides substrates, enzymes, cellular cytokines, chemokines, monoclonal antibodies, DNA vectors, RNA, growth factors, cell lysate, extracellular matrix and conditioned media for growing cells for scientific, laboratory or medical research | ACTIVE | — |
| 005 | Immune cells, namely, cells for medical or veterinary use; tissue cells, namely, cells for medical or veterinary use; biological tissues cultures, namely, stem cells, progenitor cells, immune cells, tumor cells, blood-derived cells, stromal cells, connective tissue, support tissue, organ tissue, adipose and soft tissue, vascular tissue, skin and surface tissues, mucosal tissue, neural tissue, decellularized tissue, demineralized tissue, umbilical cords, placentas, bone marrow and tumor tissue for medical or veterinary use; derivatives of immune cells, tissue cells, and biological tissues, namely, vaccines, proteins, peptides substrates, cellular cytokines, chemokines, monoclonal antibodies, DNA vectors, RNA, growth factors, cell lysate, extracellular matrix, and conditioned media for medical or veterinary use. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 7, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 12, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 12, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 6, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 16, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 15, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 15, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 15, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 7, 2026 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Jan 7, 2026 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Oct 17, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 17, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 17, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 9, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 2, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 23, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 23, 2025 | NWAP | NEW APPLICATION ENTERED | — |